NEFL and Parkinson disease: Consistently, higher baseline plasma NfL concentrations (i.e. 2.7-fold increase) were significantly associated with worse motor and cognitive outcome, i.e. increase of 9.7 points of MDS-UPDRS III and decrease of 2.1 points of MMSE, respectively in PD patients with PIGD subtype (Ng et al. 2020).